Ruth Wong

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Health Information

Respiratory Syndrome Coronavirus

Early Breast Cancer

Top Venues

Health technology assessment (Winchester, England)

PharmacoEconomics

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Davis, Emma Simpson, Jean Hamilton, Marrissa Martyn-St James, Andrew Rawdin, Ruth Wong, Edward Goka, Neil J Gittoes, Peter Selby
Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation. Health technology assessment (Winchester, England) 24 (29) (2021)
Ana Duarte, Simon M Walker, Andrew Metry, Ruth Wong, Jasmina Panovska-Griffiths, Mark J Sculpher
Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies. PharmacoEconomics 39 (8) (2021)
Paul Tappenden, Christopher Carroll, Jean Hamilton, Eva Kaltenthaler, Ruth Wong, Jonathan Wadsley, Laura Moss, Sabapathy P Balasubramanian
Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model. Health technology assessment (Winchester, England) 23 (8) (2020)
S E Harnan, Paul Tappenden, Katy Cooper, John W Stevens, Alice Bessey, Rachid Rafia, Sue E Ward, Ruth Wong, Robert C Stein, Janet Brown
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis. Health technology assessment (Winchester, England) 23 (30) (2020)